http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101825637-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9305fc720f87097494d965f1b1310e24
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17
filingDate 2017-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7213ddb9b0c17bdb1e93d7b2949f605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ab0d67915045f1aeacd9a4c10d71fef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8745b16d764b4dfce4d88b0ddef0f3ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed9f7f73b799dc1447c606de9b649b26
publicationDate 2018-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101825637-B1
titleOfInvention A pharmaceutical composition for prevention or treatment of cancer and use thereof
abstract The present invention relates to a pharmaceutical composition for preventing or treating cancer, comprising homoharringtonine and isolated natural killer (NK) cells, and uses thereof. Homoharringtonone increases the susceptibility of cancer cells to NK cells and increases the cytotoxicity of NK cells to cancer cells. As a result, the composition of the present invention significantly increases the anticancer effect by the combination treatment of homoharringtonine and NK cells Synergy appears.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020190071-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022080729-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102172871-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200073809-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022255583-A1
priorityDate 2017-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006050270-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015104292-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID80328
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID109256435
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID102547056
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00759
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID79465
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID27007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419541114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544653
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID215728
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449915478
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68772216
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID80329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7937
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID285033
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID22914
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID450153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453197090
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24934
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID102120479
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID221067
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID574240

Total number of triples: 46.